ArticleThoracic cancer2023

The development of a tumor-associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor-based treatment in patients with advanced non-small-cell lung cancer.

Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.